THE USE OF INTRAVENOUS KETOROLAC FOR THE TREATMENT OF RENAL COLIC IN THE EMERGENCY DEPARTMENT

被引:21
作者
LARSEN, LS [1 ]
MILLER, A [1 ]
ALLEGRA, JR [1 ]
机构
[1] MORRISTOWN MEM HOSP,RESIDENCY EMERGENCY MED,MORRISTOWN,NJ 07960
关键词
RENAL COLIC; NEPHROLITHIASIS; NSAIDS; KETOROLAC;
D O I
10.1016/0735-6757(93)90123-S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The objective of this study was to report the authors' experience using intravenous ketorolac (Syntex Laboratories, Palo Alto, CA) as an analgesic in the treatment of renal colic in a convenience sample at three suburban community hospital emergency departments. Twenty-five patients with renal colic were participants. Pregnant women, patients with a history of renal or hepatic impairment, bleeding diathesis, active peptic ulcer disease, or hypersensitivity to aspirin or nonsteroidal antiinflammatory drugs (NSAID) were excluded. Ketorolac 30 mg administered intravenously during a 1-minute period, and the following parameters were monitored at times 0, 5, 10, 20, 30, and 60 minutes: pain on a scale of 0 to 10, pulse rate, blood pressure, and adverse side effects. A total of 25 patients were included in our series. Initially, they had a median pain score of 9 with an interquartile range of 1. Thereafter, the median pain scores and (interquartile ranges) were 8 (three) at 5 minutes, 5 (four) at 10 minutes, 2 (four) at 20 minutes, 1 (three) at 30 minutes, and 0 (one) at 60 minutes. There were no adverse side effects observed in any patients. Therefore, it can be concluded that intravenous ketorolac is an effective analgesic agent for the control of pain in patients with renal colic. © 1993.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 26 条
[1]  
McLellan, Goodell, Pain from the bladder ureter and renal pelvis, Assoc Nerv Ment Dis, 23, pp. 252-262, (1942)
[2]  
Dik, Fritz, Schrouder, Et al., A randomized double blind study of intravenous administration of ketorolac tromethamine compared with placebo for the treatment of ureteric colic following electro shockwave lithotripsy, J Urol, 137, (1987)
[3]  
Brown, Moodie, Vicki, Et al., Comparison of intravenous ketorolac tromethamine and morphine sulfate in post-operative pain, Pharmocotherapy, 10, pp. 116s-121s, (1990)
[4]  
Peirce, Fragen, Pemberton, Intravenous ketorolac tromethamine versus morphine sulfate in the treatment of immediate postoperative pain, Pharmacotherapy, 10, pp. 111s-115s, (1990)
[5]  
Duarte, Dunaway, Turner, Et al., Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: A randomized prospective, double-blind trial, Ann Emerg Med, 21, pp. 1116-1121, (1992)
[6]  
Larkin, Prescott, A randomized, double blind comparative study of the efficacy of ketorolac tromethamine versus meperidine in the treatment of severe migraine, Ann Emerg Med, 21, pp. 919-924, (1992)
[7]  
Wright, Norris, Mitchell, Ketorolac for sicle cell vaso-occlusive crisis pain in the emergency department: Lack of a narcotic-sparing effect, Ann Emerg Med, 21, pp. 925-928, (1992)
[8]  
Camu, Cardiac and circulatory effects of ketorolac tromethamine and morphine sulfate in anaesthetized patients, A New Potent Analgesic for Parenteral and Oral Administration, (1988)
[9]  
Murray, Brockway, Kenny, Comparison of the cardiorespiratory effects of ketorolac and alfentanil during propofol anaesthesia, Br J Anaesth, 63, pp. 601-603, (1989)
[10]  
Jung, Mroszczak, Bynum, Pharmacokinetics of ketorolac tromethamine in humans after intravenous, intramuscular and oral administration, Eur J Clin Pharmacol, 35, pp. 423-425, (1988)